Bausch Health Companies Inc.
BHC · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $1 | $3 | $2 | $3 |
| % Growth | -64% | 12% | -11.7% | – |
| Cost of Goods Sold | -$1 | $1 | $1 | $1 |
| Gross Profit | $2 | $2 | $2 | $2 |
| % Margin | 173.2% | 69.8% | 69% | 71.6% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $1 | $1 | $1 | $1 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $1 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $1 | $1 | $1 | $1 |
| Operating Income | $1 | $0 | $0 | $1 |
| % Margin | 67.9% | 17.5% | 12.2% | 21.8% |
| Other Income/Exp. Net | -$0 | -$0 | -$0 | -$0 |
| Pre-Tax Income | $0 | $0 | -$0 | $0 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | $0 | $0 | -$0 | $0 |
| % Margin | 19.6% | 5.8% | -2.6% | 3.6% |
| EPS | -0.24 | 0.4 | -0.16 | 0.25 |
| % Growth | -160% | 350% | -164% | – |
| EPS Diluted | -0.24 | 0.4 | -0.16 | 0.25 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $2 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | $3 | $1 | $1 | $1 |
| % Margin | 276.3% | 30.2% | 26.6% | 35.2% |